Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Aug;27(8):1906–1908. doi: 10.1128/jcm.27.8.1906-1908.1989

Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.

L S Siegel 1
PMCID: PMC267699  PMID: 2768475

Abstract

Twenty-five serum specimens from personnel immunized with botulinum pentavalent toxoid (ABCDE) had titers of neutralizing antibodies to type A (5.7 to 51.6 IU/ml), type B (0.75 to 18 IU/ml), and type E (0.61 to 10 IU/ml) botulinum toxins. Titers for one type could not be used to predict titers for another type in individuals receiving the toxoid. Cross-neutralizing antibodies to type F botulinum toxin were not detected (less than 0.0125 IU/ml).

Full text

PDF
1906

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eklund M. W., Poysky F. T., Wieler D. I. Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States. Appl Microbiol. 1967 Nov;15(6):1316–1323. doi: 10.1128/am.15.6.1316-1323.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FIOCK M. A., CARDELLA M. A., GEARINGER N. F. STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD. J Immunol. 1963 May;90:697–702. [PubMed] [Google Scholar]
  3. Fernández R. A., Ciccarelli A. S., Arenas G. N., Giménez D. F. Primer brote de botulismo por Clostridium botulinum subtipo Af. Rev Argent Microbiol. 1986;18(1):29–31. [PubMed] [Google Scholar]
  4. Giménez D. F., Ciccarelli A. S. Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol Orig. 1970;215(2):212–220. [PubMed] [Google Scholar]
  5. Hatheway C. L., McCroskey L. M. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol. 1987 Dec;25(12):2334–2338. doi: 10.1128/jcm.25.12.2334-2338.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hatheway C. L. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies. Appl Environ Microbiol. 1976 Feb;31(2):234–242. doi: 10.1128/aem.31.2.234-242.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hoffman R. E., Pincomb B. J., Skeels M. R. Type F infant botulism. Am J Dis Child. 1982 Mar;136(3):270–271. doi: 10.1001/archpedi.1982.03970390084021. [DOI] [PubMed] [Google Scholar]
  8. MOLLER V., SCHEIBEL I. Preliminary report on the isolation of an apparently new type of CI. botulinum. Acta Pathol Microbiol Scand. 1960;48:80–80. doi: 10.1111/j.1699-0463.1960.tb04741.x. [DOI] [PubMed] [Google Scholar]
  9. Midura T. F., Nygaard G. S., Wood R. M., Bodily H. L. Clostridium botulinum type F: isolation from venison jerky. Appl Microbiol. 1972 Aug;24(2):165–167. doi: 10.1128/am.24.2.165-167.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Yang K. H., Sugiyama H. Purification and properties of Clostridium botulinum type F toxin. Appl Microbiol. 1975 May;29(5):598–603. doi: 10.1128/am.29.5.598-603.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES